LABD
Direxion Daily S&P Biotech Bear 3X ETF
LABD
Closed
$6.27
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
LABD was created on 2015-05-28 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.
Company
Direxion
Asset class
Equity
Inception date
2015
Investment segment
Health Care
ISIN
US25461H8530
Website
Key stats
Open
$6.47
Volume
20.23M
AUM
$71.12M
Prev. close
$6.29
Expense ratio
1.07%
P/E
0.00
$6.03
Day’s Range
$6.53
$5.91
52W Range
$23.02
What’s in the fund
13
Total holdings
Goldman Finl Sq Trsry Inst 506
61.61%
Dreyfus Govt Cash Man Ins
48.45%
Goldman Sachs Fin Gov 465 Institut
35.77%
Dreyfus Trsry Securities Cash Mgmt
7.29%
Cash
0.57%
Citi Collateral
0.00%
S&P Biotechnology Select Industry Index Swap
-0.46%
Goldman Collateral
-1.09%
S&P Biotechnology Select Industry Index Swap
-1.92%
Others
-50.22%
Returns
Performance
_
Difference
_
Direxion Daily S&P Biotech Bear 3X ETF
Jun
30
Dividends
The last payment date was Jun 30, 2026
Div. per Share
$0.08
Div. Yield
1.20%
Div. Growth YoY
-11.90%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply